Shaowei Li
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Identification of a stromal immunosuppressive barrier orchestrated by SPP1+/C1QC+ macrophages and CD8+ exhausted T cells driving gastric cancer immunotherapy resistance.
Journal: Frontiers in immunology
Published: April 26, 2025
Predicting Immunotherapy Outcomes in NSCLC Using RNA and Pathology from Multicenter Clinical Trials.
Predicting Immunotherapy Outcomes in NSCLC Using RNA and Pathology from Multicenter Clinical Trials.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 02, 2025
Targeting adenosine enhances immunotherapy in MSS colorectal cancer with EGFRvIII mutation.
Journal: Journal for immunotherapy of cancer
Published: January 07, 2025
Immunotyping the Tumor Microenvironment Reveals Molecular Heterogeneity for Personalized Immunotherapy in Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 26, 2024
Focus on odontoblast polarization: Characteristics, regulatory factors and research platforms.
Journal: International endodontic journal
Published: October 28, 2024
A novel Cdc42-YAP-fibronectin signaling axis regulates ameloblast differentiation during early enamel formation.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: July 14, 2024
Mutual exclusivity and co-occurrence patterns of immune checkpoints indicate NKG2A relates to anti-PD-1 resistance in gastric cancer.
Journal: Journal of translational medicine
Published: May 14, 2024
Tumor microenvironment RNA test to predict immunotherapy outcomes in advanced gastric cancer: The TIMES001 trial.
Journal: Med (New York, N.Y.)
Published: February 06, 2024
Corrigendum: PET/Ct Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients.
Journal: Frontiers in oncology
Published: March 14, 2022
Last Updated: 09/26/2026